Table 2.

Initial dosages of systemic glucocorticoid active substances that had a side effect recorded within 31 days after receiving systemic glucocorticoid therapy among dogs under primary veterinary care in the UK (n = 120).

Active substance	No. dogs	Median	IQR	Range	Expected duration (injectable)
Oral tablets without injection (mg/kg daily)
Prednisolone 1 mg	2 (1.4)	0.14	0.11–0.17	0.11–0.17
Prednisolone 5 mg	58 (39.2)	0.67	0.44–0.92	0.20–2.22
Prednisolone 25 mg	12 (8.1)	0.89	0.65–1.29	0.40–2.50
Methylprednisolone	4 (2.7)	0.97	0.63–1.94	0.47–2.74
Prednisolone/cinchophen	1 (0.7)	0.12
Overall tablets without injection (mg/kg daily)	77 (52.0)	0.7	0.46–1.0	0.11–2.74
Tablets with prior injection (mg/kg daily)
Prednisolone 5 mg	6 (4.1)	0.48	0.37–0.54	0.20–0.75
Prednisolone 25 mg	1 (0.7)	0.89
Overall tablets with prior injection (mg/kg daily)	7 (4.7)	0.52	0.37–0.75	0.20–0.89
Injectable (mg/kg daily)
Dexamethasone isonicotinate	3 (2.0)	0.10	0.07–0.11	0.07–0.11	Intermediate
Dexamethasone phenylpropionate, dexamethasone sodium phosphate	9 (6.1)	0.07	0.06–0.09	0.05–0.20	Short to intermediate
Dexamethasone sodium phosphate	23 (15.5)	0.10	0.09–0.17	0.07–0.86	Short
Methylprednisolone acetate	1 (0.7)	2.27			Long
Overall injectables (mg/kg daily)	36 (24.3)	0.10	0.08–0.15	0.05–2.27
Total	120

Twenty-eight cases were missing bodyweight data so the daily dosage was not available.